1/
A cohort study assessing HCQ+azithro in hospitalized patients w/ #COVID19 showed no clear clinical benefit
Thx @EmoryMedicine MS3s Timothy Arleo & @sims_hershey (creators), @cg_coleman & @tylerdau (editors), & #EmoryID fellow @Boghuma (peer review)
#EducationInTheTimeOfCOVID
A cohort study assessing HCQ+azithro in hospitalized patients w/ #COVID19 showed no clear clinical benefit
Thx @EmoryMedicine MS3s Timothy Arleo & @sims_hershey (creators), @cg_coleman & @tylerdau (editors), & #EmoryID fellow @Boghuma (peer review)
#EducationInTheTimeOfCOVID
2/
This study had no control group, so a randomized-controlled trial is still needed; however, these results contradict prior studies showing substantial benefits with this combination and should call into question the results of that study.
This study had no control group, so a randomized-controlled trial is still needed; however, these results contradict prior studies showing substantial benefits with this combination and should call into question the results of that study.
3/
Here's the link to the article: sciencedirect.com/science/articl…
And here's the link to the #EmoryID fellows' scholar blog with other article summaries plus our visual abstracts & infographics by @EmoryMedicine students:
scholarblogs.emory.edu/covid19roundup/
Here's the link to the article: sciencedirect.com/science/articl…
And here's the link to the #EmoryID fellows' scholar blog with other article summaries plus our visual abstracts & infographics by @EmoryMedicine students:
scholarblogs.emory.edu/covid19roundup/
• • •
Missing some Tweet in this thread? You can try to
force a refresh
